TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vaccinia Sverige AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
10,183
|
8,134
|
5,983 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
1,766
|
1,060
|
16 |
EBITDA |
1,734
|
1,077
|
51 |
Total assets |
4,088
|
3,025
|
1,929 |
Current assets |
4,068
|
2,987
|
1,869 |
Current liabilities |
534
|
528
|
315 |
Equity capital |
3,325
|
2,308
|
1,475 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
4
![]() |
4
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
81.3%
|
76.3%
|
76.5% |
Turnover per employee |
2,546
|
2,034
|
1,994 |
Profit as a percentage of turnover |
17.3%
|
13.0%
|
0.3% |
Return on assets (ROA) |
43.2%
|
35.0%
|
0.9% |
Current ratio |
761.8%
|
565.7%
|
593.3% |
Return on equity (ROE) |
53.1%
|
45.9%
|
1.1% |
Change turnover |
2,049
|
2,151
|
-2,410 |
Change turnover % |
25%
|
36%
|
-29% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
33%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.